All cells were cultured in a final volume of 200 µl in the presence of 1 × 104 irradiated peripheral mononuclear cells as antigen-presenting cells. All tests were conducted in triplicate. Cell cultures were then incubated at 37°C for 4 days and supernatants were obtained for cytokine measurements before AZD4547 cell line being pulsed with 1 µCi [3H]-thymidine per well for the final 18 h of incubation. Plates were harvested onto nylon filters using the Betaplate system and radioactivity was quantified using a Betaplate counter. Results are expressed in counts per minute (cpm) as the mean of triplicate cultures ± standard error of the mean (s.e.m.).

Percentage suppression was calculated using the formula: (1−cpm in presence of Treg cells/cpm in the absence of Treg cells) × 100. Conventional (CD4+CD25-) and Treg (CD4+CD25high) populations were isolated from tumour samples by flow cytometry cell sorting and stimulated with the irradiated autologous CD3- fraction, containing tumour cells and tumour-associated antigen-presenting cells (APCs), in the presence or absence of IL-2 (50 ng/ml) for 10 days. Cultures were then stimulated with phorbol

myristate Nutlin-3 research buy acetate (PMA)/ionomycin and stained with anti-CD4 and anti-IL-17 mAb. The supernatants were diluted for measurement of cytokine concentration by enzyme-linked immunosorbent assay (ELISA) (R&D kits, Minneapolis, MN, USA). Briefly, microtitre plates precoated with capturing mAbs were blocked with 2% bovine serum albumin (BSA)/PBS. After washing, samples and controls Suplatast tosilate were added at 50 µl per well and incubated for 2 h with a biotinylated detecting antibody (50 µl per well) in 2% BSA/PBS/Tween-20. Plates were

washed and incubated for 30 min with streptavidin-conjugated horseradish peroxidase. Next, 100 µl of 0·0125% tetramethylbenzidine and 0·008% H2O2 in citrate buffer was used as substrate. A standard curve was performed for each plate and used to calculate the absolute concentrations of cytokines. Normally distributed data sets were analysed by Student’s t-test, paired t-test, analysis of variance (anova) and linear regression and correlation analysis (using ‘Primer for Biostatistics’). The Wilcoxon two-sample test and Kruskall–Wallis test were used for data sets that were not normally distributed (using sas). P ≤ 0·05 was considered significant. Although the high frequency of Th17 cells has been shown to correlate with favourable outcome in patients with several types of cancer, their distribution is unclear as yet in human bladder tumours. Those prompted us to assess the presence of Th17 cells in the peripheral blood and tumours tissue of patients with bladder carcinoma. PBMCs in patients with bladder carcinoma (n = 45) and in healthy controls (n = 20) were examined for the prevalence of Th17 cells.